During the tenure of the previous granting period we, as well as others, have demonstrated the presence of human papillomavirus (HPV) DNA in a variety of premalignant and malignant tumors from patients with wart disease syndromes. Since the association of HPV DNA with several of these malignant tumors is now established, the most important issue becomes whether or not these viruses contribute to the malignant phenotype. Thus, the major objective of this continuing grant application is to determine the involvement, if any, of human papillomaviruses in the progression of certain chronic or recurring wart disease syndromes to the malignant phenotype. To this end our renewal application proposes to: 1) complete our nucleotide sequencing of the HPV DNA species that we have most consistently found associated with malignant tumors both primary and metastatic (i.e., HPV-5 DNA). We also plan to complete nucleotide sequence analysis of the pertinent regions of the subgenomic and recombinant forms of HPV DNA that we have isolated in an effort to determine the possible mechanism(s) by which these variant forms of HPV DNA are derived; 2) continue our comparative analysis of the expression of HPV in both benign and malignant tissues to determine the specific HPV genetic sequences that might be involved in malignant progression; 3) alternatively, we plan to employ genetic dissection and site-specific mutagenesis of papillomavirus DNA to identify directly those nucleotide sequences responsible for malignant progression by testing such genetically altered DNAs in a DNA transfection assay in vivo using an experimental rabbit model system that we have recently developed in our laboratory; 4) molecularly clone to expression the capsid proteins of HPV-5 with the ultimate objective of determining whether such proteins can reduce the incidence of wart disease in high risk patients and concommitantly reduce the rate of malignant progression; and 5) analyze HPV gene expression in normal skin cells to determine the nature of the HPV genetic sequences required for the maintenance of HPV DNA in these cells. The methodologies that we plan to employ to achieve these objectives are for the most part already implemented in our laboratory and include a variety of physiochemical, enzymological and filter hybridization techniques available for the analysis of DNA, RNA and protein including nucleotide sequence analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA025462-09S1
Application #
3166882
Study Section
Experimental Virology Study Section (EVR)
Project Start
1979-04-01
Project End
1988-12-31
Budget Start
1988-04-01
Budget End
1988-12-31
Support Year
9
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Chan, S Y; Ostrow, R S; Faras, A J et al. (1997) Genital papillomaviruses (PVs) and epidermodysplasia verruciformis PVs occur in the same monkey species: implications for PV evolution. Virology 228:213-7
Chan, S Y; Bernard, H U; Ratterree, M et al. (1997) Genomic diversity and evolution of papillomaviruses in rhesus monkeys. J Virol 71:4938-43
Liu, Z; Ghai, J; Ostrow, R S et al. (1995) The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential. Virology 207:260-70
Liu, Z; Ghai, J; Ostrow, R S et al. (1994) The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotransfection with activated Ha-ras. Virology 201:388-96
Ostrow, R S; Liu, Z; Schneider, J F et al. (1993) The products of the E5, E6, or E7 open reading frames of RhPV 1 can individually transform NIH 3T3 cells or in cotransfections with activated ras can transform primary rodent epithelial cells. Virology 196:861-7
McGlennen, R C; Ghai, J; Ostrow, R S et al. (1992) Cellular transformation by a unique isolate of human papillomavirus type 11. Cancer Res 52:5872-8
Schneider, J F; McGlennen, R C; LaBresh, K V et al. (1991) Rhesus papillomavirus type 1 cooperates with activated ras in transforming primary epithelial rat cells independent of dexamethasone. J Virol 65:3354-8
Ostrow, R S; LaBresh, K V; Faras, A J (1991) Characterization of the complete RhPV 1 genomic sequence and an integration locus from a metastatic tumor. Virology 181:424-9
McGlennen, R C; Ostrow, R S; Carson, L F et al. (1991) Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected cervical tissues. Am J Obstet Gynecol 165:696-705
Ostrow, R S; McGlennen, R C; Shaver, M K et al. (1990) A rhesus monkey model for sexual transmission of a papillomavirus isolated from a squamous cell carcinoma. Proc Natl Acad Sci U S A 87:8170-4

Showing the most recent 10 out of 34 publications